Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Werewolf Therapeutics (HOWL) Profit After Tax (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Profit After Tax for 5 consecutive years, with -$8.4 million as the latest value for Q4 2025.

  • Quarterly Profit After Tax rose 58.92% to -$8.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$60.8 million through Dec 2025, up 13.75% year-over-year, with the annual reading at -$60.8 million for FY2025, 13.75% up from the prior year.
  • Profit After Tax for Q4 2025 was -$8.4 million at Werewolf Therapeutics, up from -$16.4 million in the prior quarter.
  • The five-year high for Profit After Tax was -$5.1 million in Q2 2023, with the low at -$20.4 million in Q4 2024.
  • Average Profit After Tax over 5 years is -$13.6 million, with a median of -$14.2 million recorded in 2021.
  • The sharpest move saw Profit After Tax skyrocketed 65.07% in 2023, then crashed 238.35% in 2024.
  • Over 5 years, Profit After Tax stood at -$17.9 million in 2021, then soared by 33.24% to -$11.9 million in 2022, then dropped by 0.61% to -$12.0 million in 2023, then crashed by 69.96% to -$20.4 million in 2024, then surged by 58.92% to -$8.4 million in 2025.
  • According to Business Quant data, Profit After Tax over the past three periods came in at -$8.4 million, -$16.4 million, and -$18.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.